Grow with a partner who treats your market like their own.
We're in constant search of partners who match our values, work ethics and commitment to patients. Partnership and collaboration are an integral part of our business strategy — from in/out-licensing of products and technologies, to joint ventures and asset acquisition.
Our prescription business is built on branded generics, promoted by our medical representatives in emerging markets. Key focus markets include Azerbaijan, Russia, South Africa, Brazil, Mexico, the Indian sub-continent, Philippines, Vietnam and the United States.
We have a strong consumer healthcare presence in Azerbaijan, Guatemala, Mozambique, Russia, Nigeria and the USA — combining global integrated capabilities with on-the-ground commercial experience.

Direct to leadership
business@vitaaglobalbioscience.comPick the model that fits your market.
Distribution Partnership
Become an exclusive or non-exclusive distributor in your market — we'll provide dossiers, marketing toolkits and ongoing supply.
Brand & Private Label
Launch under your own brand with our manufacturing, regulatory and supply backbone.
In/Out-Licensing
License our molecules and dossiers, or out-license your IP to us for emerging market commercialization.
Joint Ventures
Co-develop products and share commercial upside in strategic markets.
We're open to collaborations across these therapy areas.
Prescription business across emerging markets, consumer healthcare in key high-growth geos.
Our medical representatives promote branded generics in Azerbaijan, Russia, South Africa, Brazil, Mexico, the Indian sub-continent (Myanmar, Sri Lanka, Bangladesh), Philippines, Vietnam and the USA. Consumer healthcare leads in Azerbaijan, Guatemala, Mozambique, Russia, Nigeria and the USA.
Asia
13 countries
Africa
14 countries
Europe & CIS
15 countries
Oceania
3 countries
Tell us about your market — we'll respond in one working day.
From a single SKU enquiry to a full contract manufacturing partnership, our commercial team is ready with prices, dossier samples and lead times.
